現在地

鍋倉 宰(ナベクラ ツカサ; Nabekura, Tsukasa)

研究者情報全体を表示

会議発表等
  • Tracking the Fate of Antigen-specific Versus Cytokine-activated Natural Killer Cells after Cytomegalovirus Infection
    Nabekura Tsukasa
    The 3rd International Conference of Innate Lymphoid Cel/2018-11
  • Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection
    Nabekura Tsukasa
    RIKEN Center for Integrative Medical Sciences (IMS) – Japanese Society of Immunology (JSI) International Symposium on Immunology 2018/2018-06
  • 活性化受容体NKG2D はマウスサイトメガロウイルス感染時のナチュラルキラー細胞の増殖を促進するが、NKG2D シグナル単独では増殖に不十分である
    鍋倉 宰
    第6回筑波大学・東京理科大学合同リトリート/2018-03-17
  • Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection
    Nabekura Tsukasa
    The 46th Annual Meeting of the Japanese Society of Immunology/2017-12
  • 共刺激分子DNAM-1はサイトメガロウイルス感染時に於ける記憶ナチュラルキラー分化に必要である
    鍋倉 宰; 金谷 穣; 渋谷 彰; Guo Fu; Gascoigne Nicholas ...
    第9回血液疾患・免疫療法学会学術集会/2017-09-30
  • 自己MHCクラスIを認識する活性化NK細胞受容体はNK細胞のエフェクター機能と記憶細胞分化を促進する
    鍋倉 宰
    第9回血液・疾患免疫療法学会学術集会/2017-09-30
  • Activating receptors for self-MHC class I enhance effector functions and memory differentiation of NK cells during mouse cytomegalovirus infection
    Nabekura Tsukasa
    第26回東京免疫フォーラム/2017-03
  • Natural killer cell licensing and tolerance modulate differentiation of natural killer cells during mouse cytomegalovirus infection
    Nabekura Tsukasa
    The 44th Annual Meeting of the Japanese Society of Immunology/2015-11
  • DNAM-1 is required for expansion of effector NK cells and generation of memory NK cells during mouse cytomegalovirus infection
    Nabekura Tsukasa
    IMMUNOLOGY 2013 AAI Annual Meeting at Honolulu/2013-05
  • 活性化免疫受容体DNAM-1の急性肝GVHDの病態形成における重要な役割
    金谷 穣; 渋谷 和子; 阿部 史枝; 鍋倉 宰; 渋谷 彰
    第4回造血器腫瘍免疫療法研究会学術集会/2012-08-18
  • The role of CD155, a novel co-stimulatory molecule in CD4+ T cells, in contact dermatitis
    Yumi Kanemaru; Yuichi Takahashi; Yinan Wang; Aya Yoshioka...
    第40回 日本免疫学会総会・学術集会/2011-11
  • A critical role of DNAM-1 in the development of acute graft-versus-host disease
    Nabekura Tsukasa
    The 5th Tsukuba Medical Science Research Meeting/2011-01
  • Identification and characterization of the poliovirus receptor(CD155)as a novel co-stimulatory molecule in CD4+ T cells.
    Yamashita Y; Wang Y; Yoshioka A; Nabekura T; Tahara-Hanao...
    第14回国際免疫学会議/2010-08-27
  • Identification and characterization of the poliovirus receptor(CD155)as a novel co-stimulatory molecule in CD4+ T cells.
    Yamashita Y; Wang Y; Yoshioka A; Nabekura T; Tahara-Hanao...
    第14回国際免疫学会議/2010-08-26
  • Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
    Nabekura Tsukasa
    The 2nd Society of Immunotherapy for Hematological Malignancies/2010-08
  • A critical role of DNAM-1 in the development of acute graft-versus-host diseas
    Nabekura Tsukasa
    The 14th International Congress of Immunology/2010-08
  • DNAM-1は移植片対宿主病の発症において重要な役割を果たす
    鍋倉 宰; 渋谷 和子; 竹中 江里; 渋谷 彰
    第20回Kyoto T Cell Conference/2010-06-05
  • A critical role of DNAM-1 in the development of acute graft-versus-host disease
    Nabekura Tsukasa
    The Keystone Symposia on Molecular and Cellular Biology (Lymphocyte Activation)/2010-02
  • Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
    Nabekura Tsukasa
    The 39th Annual Meeting of the Japanese Society of Immunology/2009-12
  • Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
    Nabekura Tsukasa
    The 71st Annual Meeting of the Japanese Society of Hematology/2009-10
  • Induction of tumor-specific T cells by inoculation of genetically modified dendritic cells
    Nabekura Tsukasa
    The 18th Kyoto T Cell Conference/2008-06
  • An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
    Nabekura Tsukasa
    The 37th Annual Meeting of the Japanese Society of Immunology/2007-11
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 13th Annual Meeting of the Japan Society of Gene Therapy/2007-06
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 36th Annual Meeting of the Japanese Society of Immunology/2006-12
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 12th Annual Meeting of the Japan Society of Gene Therapy/2006-08